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Background: Early prognosis in comatose survivors after cardiac arrest due to ventricular 
fibrillation (VF) is unreliable, especially in patients undergoing mild hypothermia. We 
aimed at developing a reliable risk-score to enable early prediction of cerebral performance 
and survival. 
Methods: Sixty-one out of 239 consecutive patients undergoing mild hypothermia after 
cardiac arrest, with eventual return of spontaneous circulation (ROSC), and a comatose 
status on admission fulfilled the inclusion criteria. Background clinical variables, VF time 
and frequency domain fundamental variables were considered. The primary and secondary 
outcomes were a favorable neurological performance (FNP) during hospitalization and 
survival to hospital discharge, respectively. The predictive model was developed in a 
retrospective cohort (n=32; September 2006-September 2011, 48.5±10.5 months of follow-
up) and further validated in a prospective cohort (n=29; October 2011-July 2013, 5±1.8 
months of follow-up).  
Results: FNP was present in 16 (50.0%) and 21 patients (72.4%) in the retrospective and 
prospective cohorts, respectively. Seventeen (53.1%) and 21 patients (72.4%), respectively, 
survived to hospital discharge. Both outcomes were significantly associated (p<0.001). 
Retrospective multivariate analysis provided a prediction model (sensitivity=0.94, 
specificity=1) that included spectral dominant frequency, derived power density and peak 
ratios between high and low frequency bands, and the number of shocks delivered before 
ROSC. Validation on the prospective cohort showed sensitivity=0.88 and specificity=0.91. 
A model-derived risk-score properly predicted 93% of FNP. Testing the model on follow-
up showed a c-statistic ≥0.89. 
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Conclusions: A spectral analysis-based model reliably correlates time-dependent VF 
spectral changes with acute cerebral injury in comatose survivors undergoing mild 



















Both in-hospital and out-of-hospital cardiac arrest due to ventricular fibrillation (VF) are 
associated with high mortality rates and significant cerebral disability.[1, 2] VF-derived 
cerebral injury is a very sensitive time-dependent condition with dramatic social and 
personal consequences. The absence of cerebral blood flow during VF leads to ischemic 
damage within a few minutes, which increases after reperfusion due to generation of 
oxygen free radicals and activation of degradation enzymes, together with other 
mediators.[3] To date, mild hypothermia is the only therapy that has shown to increase 
survival rates and functional outcomes in comatose survivors of cardiac arrest due to VF,[4-
6] even though cardiopulmonary resuscitation (CPR) technique and some specific drugs are 
considered influential during resuscitation. However, the use of sedative and neuromuscular 
blocking drugs in cooled patients may mask neurological damage and delay examination. 
Furthermore, early prognosis within the first 72 h after cardiac arrest remains unreliable, 
which is especially relevant in those patients undergoing highly specialized intensive care 
who might not have any hopes for recovery. 
Reducing the time to DC shock after VF onset is vital to restore spontaneous circulation and 
minimize cerebral injury.[7] However, the exact time in VF is difficult to determine even 
after witnessed cardiac arrest. Many VF episodes may initiate as ventricular tachycardia and 
cerebral blood flow might still persist until VF develops.[8] Reliable experimental data 
from waveform analysis during VF indicate that both spectral dominant frequency (DF) and 
median frequency decrease after onset of VF.[9, 10] In the clinical setting, such a decrease 
in spectral values correlates with poor defibrillation success and no return of spontaneous 
circulation (ROSC).[11] Moreover, retrospective data in patients with out-of-hospital 
cardiac arrest and VF have shown that a 5.61 Hz DF threshold can serve as a good predictor 
for 1-year survival after discharge.[12] Therefore, we hypothesize that spectral analysis of 
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VF before a DC shock will accurately reflect the degree of acute cerebral injury as a 
consequence of time in VF and concomitant myocardial ischemia. 
Here, we analyzed VF waveform properties before the first DC shock in patients 
undergoing therapeutic hypothermia due to comatose status after advanced life support 
(ALS) and ROSC.  We aimed to identify spectral parameters that in combination with 
clinical variables may serve to develop a reliable model and risk score to enable early 
prediction of cerebral performance and survival to hospital discharge. We also studied the 
capacity of the model to predict both outcomes at follow-up.  
2. Methods. 
2.1. Study design. 
The study was performed in a referral center for out-of-hospital cardiac arrest (Hospital 
Universitario La Paz, Madrid, Spain), in which mild therapeutic hypothermia is routinely 
used in comatose survivors after the event. The emergency service and ambulances in the 
region have trained medical staff and nurses, all coordinated by a central station to 
minimize both time to ALS and transportation to a referral center. The study included 
consecutive patients who underwent mild hypothermia after cardiac arrest due to VF, 
eventually with ROSC, and comatose status (Glasgow Coma Scale ≤ 8) on admission. 
Patients with witnessed or un-witnessed documented VF were eligible for the study, as long 
as VF traces before the first DC shock had enough quality and duration (≥3 s) for 
digitization and analysis of spectral parameters, respectively. We excluded patients with 
early mortality or hemodynamic instability leading to incomplete 24-h of mild hypothermia, 
and absence of subsequent withdrawal of sedation to assess cerebral performance. Other 
exclusion criteria were age <18 years, Glasgow Coma Scale score after ROSC >8, non-
shockable or shockable rhythms other than VF, a terminal illness or cognitive deterioration 
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present before the cardiac arrest, and possible causes of coma other than cardiac arrest. The 
study was divided in two groups, as follows: Group 1 with eligible patients from September 
2006 to September 2011 and retrospective data analysis, and Group 2 with eligible patients 
from October 2011 to July 2013, in whom we prospectively studied the utility of the 
predictive algorithm developed in Group 1. All data were collected from a 
prospective registry. The institutional ethics review committee approved prospective 
analysis of the patients, in accordance with the ethical guidelines of the 1975 Declaration of 
Helsinki and European guidelines for good clinical practice.  
2.2 Hypothermia protocol. 
Patients admitted to the acute cardiac care unit (ACCU) underwent routine neurological 
evaluation before sedation, drug-induced paralysis and initiation of hypothermia protocol as 
described elsewhere.[6] Briefly, cooling with intravenous cold saline (<8°C) was initiated 
on admission. This was followed by direct cooling of the blood using the Icy catheter 
(ZOLL Medical Corporation, Chelmsford, MA) positioned at the level of the inferior vena 
cava through the femoral vein. Cooling was set at a maximum rate with a target temperature 
either at 32, 33 or 34°C, which was maintained during 24 hours. Rewarming was controlled 
at a set rate of 0.1 to 0.3°C per hour to reach 37°C in 12 to 24 hours. Mechanical ventilation 
was adjusted to ensure normoxemia and normocapnia. Mean blood pressure was maintained 
between 85 and 100 mm Hg. Blood glucose level was ensured <10 mmol/l. Limitation of 
active ALS was considered in patients who remained deeply comatose after 5 days of 
evolution, as long as it was possible to reach an agreement with their representatives.  
2.3. Spectral Analysis. 
For each patient, we analyzed VF epochs prior to the first DC shock. Digitization was 
performed using a supervised semi-automatic approach based on region of interest selection, 
  8 
histogram thresholding and intensity transformations. Up to 5-s long segments were 
extracted after segmentation and signal codification from artifact-free VF tracings. Signals 
were band-pass filtered between 1.5 and 40 Hz. Quality of extraction was visually inspected 
by two independent investigators. Averaged power spectral density was obtained at each 
frequency using the non-parametric Welch method for using fast Fourier transform and 
normalized to the peak power in the 1.5-10 Hz band for each patient. Both time and 
frequency domain variables were quantified across patients. Those included VF amplitude 
over time, amplitude spectral area (AMSA), DF, median frequency, approximate entropy 
regularity index, spectral regularity index, 1-Hz DF spectral concentration and normalized 
80% power spectral density (see Figure 1 and Supplemental Methods for details). 
Investigators blinded to clinical outcome performed all data analysis, extraction and 
quantification using custom-made scripts of MATLAB software (V. 2010b, The Mathworks 
Inc, Natick, MA).   
2.4. Outcome. 
The primary outcome was a favorable neurological performance (FNP) during 
hospitalization. All patients were classified using the Pittsburgh outcome categorization of 
brain injury as follows: cerebral performance categories (CPC) 1 and 2 (good and moderate 
disability, respectively) were considered as FNP, and CPC 3, 4 and 5 (severe disability, 
vegetative state and brain death, respectively) were considered as a non-FNP (Supplemental 
Table 1).[13] Neurological outcome was established after in-hospital stabilization or before 
hospital discharge. In patients from group 1, retrospective data were obtained from clinical 
records during hospitalization.  
The secondary outcome measure was survival to hospital discharge. 
2.5. Follow-up. 
  9 
Neurological outcome was prospectively assessed by in-person interview in all survivors 
after October 2011, either from group 1 or group 2. Specifically, patients from group 2 were 
evaluated between 3 and 6 months after hospitalization. Neurological outcome was also 
determined in both groups using the mini-mental state examination as follows: any score 
≥24 points (out of 30) indicated a good cognition. Scores <24 indicated cognitive 
impairment.[14] Only patients with both CPC ≤2 and mini-mental state examination score 
≥24 were considered to have FNP at follow-up. 
Survival after hospitalization was assessed in group 1 after October 2011. In patients from 
group 2, survival was assessed at 6 months after hospital discharge.  
2.6. Statistical Analysis. 
All values are presented as median±SEM (25th,75th percentiles) except where noted. The 
retrospective cohort was used to develop a model for predicting the primary outcome. Each 
of the clinical, spectral and time domain VF variables underwent univariate analysis to 
evaluate its association with in-hospital FNP. Normal distribution of variables was assessed 
with Shapiro-Wilk test. Statistical significance was assessed by the T-test or the Mann-
Whitney-Wilcoxon test, as appropriate. If necessary, we used Bonferroni correction for 
multiple comparisons. Categorical variables and percentile comparisons were compared 
using a Chi-squared test or the Fisher Exact test, as appropriate. P<0.05 was considered 
statistically significant. Non-correlated variables, amongst statistically significant ones 
(Supplemental Figure 1), and clinical relevant variables were regressed out against the 
primary outcome by using a stepwise backward multivariate logistic regression approach. 
We aimed at predicting in-hospital FNP with the highest sensitivity and specificity 
achievable using the minimum number of variables. We validated the predictive accuracy 
of the model in the prospective cohort and tested the model during follow-up. We also 
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studied in both groups the accuracy of the model in predicting survival. Patients from both 
groups were categorized according to their risk scores obtained in the multivariate analysis. 
Goodness of fit was assessed through Pearson residuals and Chi-squared deviance. To 
correct for bias, we obtained bootstrapped standard errors for weights. To guarantee 
robustness we used the Jackknife fitted regression weights to confirm the minimum mean 
squared error (See Supplemental Methods for details). All analyses were done using SSPS 
v21 and custom Matlab scripts for mathematical assistance.  
3. Results.  
The workflow of the study is depicted in Figure 2. A total of 239 patients undergoing mild 
hypothermia (n=116, retrospective cohort and n=123, prospective cohort) were assessed for 
eligibility during the study period. Sixty-one patients (n=31, group 1 and n=29, group 2) 
fulfilled the inclusion criteria. The vast majority of patients were included after out-of-
hospital cardiac arrest (n=57). However, two patients in each group were included after in-
hospital cardiac arrest due to VF, since comatose status was present after DC shock and 
ROSC. Baseline clinical characteristics and background treatment of both groups are shown 
in Table 1. Female sex, family history of sudden cardiac death and younger age were more 
frequent in group 2. Overall, the main cause of VF was coronary heart disease, either acute 
coronary syndromes (n=27, 45%) or chronic coronary disease (n=14, 23%), followed by 
idiopathic VF (n=6, 10%) and dilated cardiomyopathy (n=6, 10%) (Supplemental Figure 2).  
3.1. Outcomes. 
Primary and secondary outcomes are shown in Table 2. Sixteen patients in group 1 (50.0%) 
and 21 patients in group 2 (72.4%) achieved FNP during hospitalization. Seventeen patients 
in group 1 (53.1%) and 21 patients in group 2 (72.4%) survived to hospital discharge. After 
a median follow-up of 48.5±10.5 months (7.0, 68.7) in group 1, 16 patients (50.0%) were 
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still alive, albeit 15 (48.8%) showed FNP. In group 2, 20 patients (68.8%) were alive at 6 
months after hospital discharge and 19 (65.5%) showed FNP after 5±1.8 months (3.5, 7.5). 
Hospitalization outcomes were not statistically different between groups (Table 2). No 
patients were missed during follow-up. Outcomes and follow-up of each individual patient 
are depicted in Supplemental Figure 3. Four patients died (6.5%) despite FNP. There was a 
statistically significant association between FNP and survival (Supplemental Table 2) in 
both groups (p<0.001).   
3.2. Prediction model. 
In creating the model we only considered the primary endpoint since mortality may occur in 
patients with FNP due to other causes non-directly related with cardiac arrest injury. The 
interval to ALS and total time of ALS reached statistical significance among clinical 
variables. All fundamental spectral and time domain VF variables, but VF signal amplitude, 
were significantly associated to the primary endpoint (p<0.05) (Table 3). Interestingly, DF 
was strongly associated with FNP, which was reflected by the best univariate independent 
predictive accuracy in the retrospective and prospective cohorts (average 0.884) (Table 3). 
A cut-off at 3.9 Hz showed the highest sensitivity (0.88) and specificity  (0.94) in predicting 
the primary endpoint in the retrospective cohort. Therefore, we used such a cut-off value to 
obtain two derived, also significant (p<0.001. Table 3), spectral variables as follows: high-
to-low power spectral density ratio (HL-PSDR), as the relative power between high (3.9-10 
Hz) and low (1.5-3.9 Hz) bands, and high-to-low peak ratio (HL-pKR), as the relative 
number of spectral peaks above and below 3.9 Hz with power above 40% of the DF (Figure 
1). Graphic representation of individual spectra and DF peaks of the entire population are 
shown in Figure 3A. The vast majority of patients with FNP during hospitalization showed 
DF values above 3.9 Hz (Figure 3A1), unlike those individuals with non-FNP, who had DF 
values below 3.9 Hz (Figure 3A2). Such differences were statistically significant both in the 
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retrospective and prospective cohorts, as well as in the entire population (p<0.001. Figure 
3B). Moreover, DF values also showed significant differences between patients who 
survived and those who did not survive to hospital discharge (p<0.001. Figure 3B).  
Multivariate analysis identified DF, HL-pKR, HL-PSDR and the number of shocks 
delivered before ROSC as the best performance model to predict in-hospital FNP. 
Multivariate adjusted odds ratios are shown in Table 4. For the primary endpoint, the model 
achieved sensitivity=0.94 and specificity=1 (c-statistic=0.98). Validation on the prospective 
cohort also showed high sensitivity (0.88) and specificity (0.91) (c-statistic=0.89). The 
multivariate model achieved sensitivity=0.94 and specificity=0.94 to predict in-hospital 
survival in the retrospective cohort (c-statistic=0.95). For the secondary endpoint, predictive 
performance was also high in the prospective group (sensitivity=0.88, specificity=0.91, c-
statistic=0.92). ROC curves of the multivariate model are shown in Supplemental Figure 4. 
In-hospital performance of the model is shown in Table 5. Performance of the model for 
both outcomes at follow-up also reached high sensitivity, specificity and c-Statistic values 
(Supplemental Table 3). 
3.3. Risk score based on the predictive performance of the model. 
We used the best performance threshold obtained by the prediction model to define four 
risk subsets of the population for non-FNP, as follows: very low and low risk of non-FNP 
(expected FNP), high and very high risk of non-FNP (expected non-FNP). Interquartile 
ranges of individual variables within each of the risk score groups are shown in 
Supplemental Table 4. Figure 4A shows the observed and predicted probability of in-
hospital FNP for the entire population. The risk score correctly classifies more than 93% of 
observations. Only 1 patient in the retrospective cohort was classified as FNP, although the 
patient was non-FNP during hospitalization (False negative. Figure 4B1). Three patients in 
  13 
the prospective cohort were identified as false negative and false positives (1 and 2 patients, 
respectively). The risk score was very reliable in predicting neurological performance in the 
subgroups of very low and very high risk of non-FNP (Figure 4, B1 and B2). Multivariate 
adjusted logistic regression weights and statistics for each of the four variables included in 
the risk score are shown in Supplemental Table 5. 
To test the reproducibility of the spectral variables present in the risk score, we quantified 
changes in the spectral components of VF prior the first reported DC shock using a 3-s 
sliding window shifted 0.2-s from the DC shock. Interestingly, spontaneous variability of 
the spectral components a few seconds (maximum available=12 s) before the DC shock did 
not reflect significant changes in neurological performance prediction and risk score 
classification for the entire population (Supplemental Figure 5). 
Further risk score validation in patients without comatose status after DC shock who did not 
undergo hypothermia (N=11), showed that risk score stratification properly provided FNP 
values in all cases, as expected (Supplemental Figure 6).  
3.4. Contribution of spectral parameters to the predictive performance of the model. 
The predictive performance of our model was highly dependent on incorporating the 
spectral variables. Thus, only considering the spectral parameters, the prediction model 
achieved high sensitivity (0.88) and specificity (0.86) in validation (c-statistic=0.88), 
compared with sensitivity=0.62 and specificity=0.66 (c-statistic=0.67) using the number of 
shocks delivered before ROSC alone. Moreover, the best clinical prediction model using the 
most influential clinical factors in the univariate analysis (Table 3), we obtained a 5-
variable model that achieved sensitivity=0.50 and specificity=0.71 (c-statistic=0.69) in the 
prospective cohort. The inclusion of additional clinical-relevant variables to achieve better 
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prediction in training resulted in further decrease in the predictive performance of the model 
in the prospective cohort (c-statistic=0.63). Overall, clinical models did not achieve c-
statistic values greater than 0.69 in the prospective cohort (Supplemental Table 6 and 
Supplemental Methods), which highlights the objective and reliable significance of spectral 
parameters. 
4. Discussion. 
We have introduced a novel practical approach aimed at predicting neurological 
performance and survival in patients undergoing therapeutic hypothermia after cardiac 
arrest due to VF and comatose status on admission. In brief, DF before the first DC shock is 
a strong independent predictor for both FNP and survival using a cut-off value of 3.9 Hz. 
To increase the predictive accuracy, multivariate analysis identified DF, HL-pKR, HL-
PSDR and the number of shocks delivered before ROSC as the best performance model to 
predict both primary and secondary outcomes. The model showed sensitivity and specificity 
values above 0.88 and 0.91 in the validation prospective cohort. We also developed a risk 
score that properly predicted 93% of the in-hospital neurological outcome observed in the 
entire cohort.  
Currently, the reliability of early prognosis in comatose survivors after cardiac arrest due to 
VF is very limited, which severely impairs the ability of physicians to provide accurate 
information to patients’ relatives and to optimize the use of intensive-resource care. 
Standardization of mild hypothermia delays neurological evaluation and prognostication 
due to sedation as well as higher rates of misleading biomarker values within the first 24-48 
h.[15] Moreover, the large variability of threshold biomarker values used to predict poor 
outcome and different measurement techniques makes it necessary to exert caution and 
question the prognostic accuracy provided by biochemical markers.  
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Clinical variables are also inconsistent in their ability to predict both survival and 
neurological performance,[16] as we also showed after developing and validating the best 
clinical prediction models. Advanced age seems to be associated with decreased survival 
after cardiac arrest and resuscitation.[17] Interestingly, old age is not associated with non-
FNP,[7] which supports the role of early and appropriate resuscitation to prevent cerebral 
injury.[18] However, FNP does not prevent later complications that may lead to in-hospital 
mortality, especially in old patients. Univariate analysis of our retrospective cohort also 
showed younger age as significantly associated with survival (data not shown). Conversely, 
age was not significantly associated with FNP. Likewise, inclusion of clinically relevant 
variables in the multivariate analysis did not result in age as a variable present in the 
predictive model. 
 
Time to CPR after collapse has been shown to correlate with functional outcome.[7] 
Moreover, when performed properly, CPR improves functional outcome.[18] However, the 
quality of CPR administered by a bystander might be extremely variable even if performed 
by trained personnel,[18, 19] which might not add significant improvement in outcome.[4] 
The strong predictive value of DF and derived spectral variables may be explained by their 
ability to provide reliable information of both the time from VF onset and the quality of 
CPR. Thus, as shown in both humans and animal models, as the VF episode evolves, 
progressive myocardial ischemia leads to gradual decline in DF values.[9, 10, 20, 21] 
Stewart AJ et al. have shown that DF values fall with increased duration of collapse from 
5.5 Hz at 3 min to a mean of 2.1 Hz at 20 min.[10] Patients with a mean DF of 3.89±0.25 
Hz did not survive longer than 6h after resuscitation, unlike patients with a mean DF of 
5.60±0.25 Hz who did survive.[10] Similar DF values (5.61 Hz) have been reported by 
Goto Y et al. to predict 1-year survival in a retrospective cohort of patients after out-of-
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hospital cardiac arrest, although data about neurological performance were missed.[12] Our 
risk score identifies DF of 5.6±0.53 Hz and 6.35±0.75 Hz at low and very low risk of non-
FNP, respectively. 
                                                                                              The latter does not necessarily 
correlates with survival, which is reflected by the fact that 2 patients during hospitalization 
and another 2 patients during follow-up died despite FNP. Previous series have shown that 
the longer the time between CPR and ROSC the lower the survival rate[1, 7], which is 
similar to what we observed in both cases with FNP and in-hospital mortality after the 
hypothermia protocol, in whom long CPR (20 and 42 min) and high number of shocks (4 
and 5) before ROSC were present. A significantly higher number of shocks delivered before 
ROSC was also present in patients with DF<3.9 Hz (Supplemental Figure 7), which 
highlights the difficulties of the heart for acute recovery. 
                                                                                                                                   Mortality 
may also occur during the hypothermia protocol before withdrawing sedation. Thus, data 
from 4 out of 5 patients, who were excluded due to early mortality and impossibility to 
assess the primary outcome, showed that risk score stratification would have predicted FNP 
in 3 out of 4 (Supplemental Table 7). However, early mortality due to other medical 
circumstances did not allow recovery and neurological assessment.  
Interestingly, CPR may increase DF values while coronary blood flow rises,[21, 22] which 
is also associated with increased probability of successful rescue shocks.[23] Increase in DF 
during resuscitation may explain false positive cases to predict FNP when CPR is delayed 
after collapse and DF is already low. The latter is supported by recent data by Freese et al. 
in patients with out-of-hospital cardiac arrest due to VF.[24] The authors showed that a 
waveform analysis algorithm to decide whether to apply an immediate defibrillatory shock 
or a CPR interval before the shock, did not improve overall survival to hospital discharge 
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compared with a standard shock-first protocol. In the study, prognosis may have been 
determined by the spectral values at the beginning of CPR. Yet, an increase in favorable VF 
waveform parameters during CPR increases the probability of ROSC and survival to 
admission.[24] 
DF alone showed the best univariate independent predictive accuracy amongst spectral 
variables. However, relying on DF alone may not be accurate in some cases; for instance 
when the DF peak is close to the cut-off value. Our multivariate model includes 2 additional 
derived measures (HL-PSDR and HL-pKR) that aided to clarify such cases. The probability 
of a favorable outcome increases as the relative power of high spectral bands (3.9-10 Hz) 
and the number of significant spectral peaks above 3.9 Hz also increase (Supplemental 
Figure 8). Recent data by Schoene et al. also highlights the role of AMSA over the course 
of the first 3 shocks during resuscitation in predicting survival and FNP in a large 
retrospective cohort of patients with out-of-hospital cardiac arrest due to VF.[25] 
Calculation of AMSA will typically provide higher AMSA values in traces with more high-
frequency content, which agrees with our results based on DF. The data is also consistent 
with However, Schoene et al. did not distinguish between patients with or without comatose 
status on admission. Moreover, the authors did not provide information about post-cardiac 
arrest care using mild hypothermia. Here, we focused on a population with baseline 
comatose status on admission and mild hypothermia as uniform therapy to minimize post-
cardiac arrest syndrome. 
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Finally, recent data prompted us to consider the role of hypothermia after cardiac arrest and 
whether a target temperate rather than controlling the body temperature at 36 °C must be 
pursued.[26] We speculate that temperature may have a minimum role in patients with very 
low risk (i.e., favorable risk score) or very high risk of cerebral injury at baseline (i.e., 
asystole). However, target temperature may matter in patients with borderline values to 
minimize post-cardiac arrest syndrome. 
                                                                                                               Altogether, the results 
support the clinical relevance of the predictive model and risk score to assist physicians and 
patients´ relatives who deal with difficult decisions after out-of-hospital cardiac arrest due 
to VF. 
5. Limitations. 
This is a single center study with a limited number of patients, in which survival rates may 
be higher than expected. However, our data is consistent with similar series in dedicated 
units that included patients after admission to the ACCU, with an initial rhythm reported as 
VF and using mild hypothermia.[26, 27] Therefore, the study population may be skewed 
towards patients with FNP, since patients who died in transit or survived to hospital 
admission but died in the emergency department or during the hypothermia protocol, before 
withdrawing sedation, were excluded.  
Differences between groups regarding age, gender and family history of sudden cardiac 
death may have occurred due to the study design. However, the highly reliable predictive 
performance of the spectral-based model compared with clinical models in the validation 
cohort, suggests that the model is suitable for clinical practice upon developing appropriate 
clinical tools. The proposed risk score will nevertheless benefit from further validation in a 
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multicenter study with more patients. Additionally, a significant number of traces were not 
available on admission, which may raise the concern of selection bias. However, our results 
are consistent with previous studies, which reduces likelihood for such bias.[10, 12, 24, 25] 
In the future, either incorporating the algorithm into external defibrillators or automated 
signal transferring from defibrillators to portable medical devices, for signal processing and 
risk score calculation, may avoid such limitation. The model will also benefit from futures 
studies aiming at direct comparisons of current biochemical and neurological markers to 
establish the net benefit on early prognosis. 
6. Conclusions. 
A spectral analysis-based model demonstrates to be highly reliable in predicting in-hospital 
FNP and survival to discharge in patients with comatose status on admission after cardiac 
arrest due to VF.  
Acknowledgment. 

















documented  rhythm  and  clinical  outcome  from  in‐hospital  cardiac  arrest  among 
children and adults. JAMA. 2006;295:50‐7. 




[4]  Bernard  SA,  Gray  TW,  Buist  MD,  Jones  BM,  Silvester  W,  Gutteridge  G,  et  al. 
Treatment  of  comatose  survivors  of  out‐of‐hospital  cardiac  arrest  with  induced 
hypothermia. N Engl J Med. 2002;346:557‐63. 
[5]  Mild  therapeutic  hypothermia  to  improve  the  neurologic  outcome  after  cardiac 
arrest. N Engl J Med. 2002;346:549‐56. 
[6] Lopez‐de‐Sa E, Rey JR, Armada E, Salinas P, Viana‐Tejedor A, Espinosa‐Garcia S, et 
al. Hypothermia  in comatose survivors  from out‐of‐hospital cardiac arrest: pilot  trial 
comparing 2 levels of target temperature. Circulation. 2012;126:2826‐33. 
[7] Rogove HJ, Safar P, Sutton‐Tyrrell K, Abramson NS. Old age does not negate good 
cerebral  outcome  after  cardiopulmonary  resuscitation:  analyses  from  the  brain 
resuscitation clinical trials. The Brain Resuscitation Clinical Trial I and II Study Groups. 
Crit Care Med. 1995;23:18‐25. 













[13]  Jennett  B,  Bond M.  Assessment  of  outcome  after  severe  brain  damage.  Lancet. 
1975;1:480‐4. 
[14]  Mungas  D.  In‐office  mental  status  testing:  a  practical  guide.  Geriatrics. 
1991;46:54‐8, 63, 6. 
[15]  Pfeifer  R,  Borner  A,  Krack  A,  Sigusch  HH,  Surber  R,  Figulla  HR.  Outcome  after 
cardiac arrest: predictive values and limitations of the neuroproteins neuron‐specific 
enolase and protein S‐100 and the Glasgow Coma Scale. Resuscitation. 2005;65:49‐55. 




prognosis  and  possible  measures  to  improve  survival.  Intensive  Care  Med. 
2007;33:237‐45. 
[18] Gallagher EJ, Lombardi G, Gennis P. Effectiveness of bystander cardiopulmonary 
resuscitation  and  survival  following  out‐of‐hospital  cardiac  arrest.  JAMA. 
1995;274:1922‐5. 
  22 











[23]  Strohmenger  HU,  Lindner  KH,  Keller  A,  Lindner  IM,  Pfenninger  EG.  Spectral 




out‐of‐hospital  cardiac  arrest  presenting  in  ventricular  fibrillation:  results  of  an 
international randomized, controlled trial. Circulation. 2013;128:995‐1002. 
[25]  Schoene P,  Coult  J, Murphy L,  Fahrenbruch C,  Blackwood  J,  Kudenchuk P,  et  al. 
Course  of  quantitative  ventricular  fibrillation  waveform  measure  and  outcome 
following out‐of‐hospital cardiac arrest. Heart Rhythm. 2014;11:230‐6. 





























































































Figure 1. Digitization and signal processing of a representative VF trace.  A. Upper panel, 
single lead VF trace from paper ECG prior to the first DC shock. Lower panel, 5-s VF 
epoch after digitization, segmentation and codification. B. Representative spectra of the VF 
trace showed in A. DF, MF, 1-Hz DF spectral concentration and PSD 80%, are shown. The 
univariate cut-off at 3.9 Hz was used to define low and high PSD bands. DF= dominant 
frequency. MF= median frequency. NSC= normalized spectral concentration. PSD= power 
spectral density. 
Figure 2. Workflow of patients included in group 1 and group 2. 
Figure 3.  A. Power spectral density (PSD) of all patients with in-hospital favorable (A1)  
and non-favorable (A2)  neurological performance. The patients are sorted based on their 
DF values. DF peaks are pointed out for each individual (black vertical dashed-line). The 
cut-off threshold of 3.9 Hz was chosen for color-coding above (red) and below (blue) the 
PSD. B.  Boxplot representation of DF comparing patients from both groups for primary 
and secondary endpoints. Boxes depict median and interquartile range (25-75%). Red dots 
are outliers at least twice the interquartile range from the median. Green dots represent 
outliers to hospital discharge who improved neurological performance during follow-up.  
Figure 4. Risk score based on the predictive performance of the model. A.  Observed 
(triangles) and predicted (circles) probability of FNP for the entire population. Blue and red 
represent FNP and non-FNP, respectively (dark fill, retrospective; light fill, prospective). 
We defined four risk groups of non-FNP performance according to their risk scores as 
follows: expected FNP; very low (VL) and low risk (L) and expected non-FNP; high (H) 
and very high risk (VH). B.  Percentage of patients (observed, dark gray and predicted, light 
gray) who belong to each of the risk score groups in both the retrospective (B1)  and 
  30 
prospective cohorts (B2) . (α) and (β) represent false negative and false positive individuals, 
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Supplemental Methods. 
Analysis of ventricular fibrillation traces. 
All data analyses, extraction and quantifications were done using custom scripts written in 
MATLAB software (version 7.11.0 R2010b, The MathWorks Inc, Natick, Massachusetts, USA). 
The scripts were developed using the retrospective cohort. Blinded investigators to clinical 
outcomes performed waveform and spectral analysis of ventricular fibrillation (VF) traces.  
a) Image digitization, signal extraction and interpretation. 
Standard ECG tape recordings were used to assess waveform parameters of VF prior to the first 
documented DC shock in all patients. Lead II traces were extracted unless artifacts were present. 
A semi-automatic approach was used for digitization using a Matlab-based custom tool. VF 
recordings were scanned to a digital image (1200 dpi) and stored in a codified digital format. To 
identify VF traces on the standard ECG-paper, image-processing techniques were applied 
involving binary thresholding, pixel-to-point conversion and transform techniques.[1, 2] When 
necessary, images were pre-processed to avoid artifacts (contrast, median filtering and 
interpolation) in the digitization process. Pixel-to-point conversion was applied using the lower 
waveform envelope. The graphical grid was used as reference for interpretation. Before signal 
processing, an independent investigator reviewed all digitized traces to ensure accurate extraction 
of VF deflections.   
b) Signal processing. 
Digitized signals were post-processed and further analyzed in Matlab. Up to 5-s artifact-free 
segments prior to the external DC shock were extracted in each patient. Signals with less duration 
were zero-padded up to 5 s. Only segments of at least 3 s were eligible for the study (Mean±Std 
duration 3.91±0.98 s, N=61).  All signals were detrended by mean removal. A 4th order 
polynomial approximation was applied to remove the baseline trend when appropriate. Then, VF 
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tracings were bandpass filtered between 1.5 and 40 Hz using 10th order Butterworth digital filters. 
Averaged power spectral density (PSD) was obtained at each frequency. We used a non-
parametric Welch method for robust Fast Fourier Transform (FFT) estimation with 0.2 Hz 
spectral resolutions in the 1.5 to 10 Hz band of interest, where at least 90% of the spectral power 
was concentrated. Spectral information in this band was normalized to the total power for each 
patient before attempting to extract any spectral variable. 
c) Extracting temporal and spectral variables. 
Both time and frequency domain pre-selected variables were extracted and quantified across 
patients. Fundamental spectral variables for VF were measured and calculated as described 
elsewhere.[3-9] Dominant frequency (DF) was defined as the frequency with the highest power 
in the 1.5 to 10 Hz band of interest. Median frequency (MF) describes the power distribution in 
the frequency spectrum and it was calculated as the frequency cut-off where 50% of the power in 
the spectrum was below (and above) in the 1.5-10 Hz band. Normalized spectral concentration at 
DF, was obtained both at 80% of the maximum PSD (PSD80%) and through all power density 
contained in the band DF±1Hz (NSC).[7] Spectral regularity index (RI) was defined as the ratio 
between the power at DF and the power in the 1.5 to 10 Hz band.[8] The Amplitude Spectral 
Area (AMSA) was calculated as the summed product of contributing frequencies weighted by the 
absolute value of power at that frequency from the PSD Welch spectrum (1.5 to 10 Hz band).[10]  
After univariate binary logistic regression analysis on the retrospective cohort, DF offered the 
best independent prediction accuracy (proportion of true results, both true positives and true 
negatives, in the population). A cut-off at 3.9 Hz showed the highest sensitivity (0.88) and 
specificity (0.94) for predicting the primary endpoint in the retrospective cohort. Therefore, we 
used the 3.9 Hz cut-off to obtain two additional derived ratios of spectral variables as 
follows:[11] High-to-Low Power Spectral Density Ratio (HL-PSDR) as the relative power 
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between high (3.9 to 10 Hz) and low (1.5 to 3.9 Hz) bands, and High-to-Low Peak Ratio (HL-
pKR) as the relative the number of spectral peaks above and below the 3.9 Hz threshold with 
power above 40% the frequency with the highest power (DF).  
We also considered time-domain waveform variables for the study. We included the mean 
amplitude over time (A) and the Approximate Entropy Regularity Index (AppEnt), which 
measures the complexity of a time sequence as the natural logarithm of the relative prevalence of 
repetitive patterns found within the sequence.[12, 13] 
For multivariate analysis, we selected non-correlated statistically significant variables among all 
extracted VF fundamental variables. Spearman and Pearson correlations were done to determine 
monotonic and linear relationships in the retrospective cohort (p<0.001). Highly correlated (Rho 
and R>0.9) variables were considered for elimination (Supplemental Figure 1), leaving those 
with the highest univariate prediction accuracy for the primary outcome. 
 
Statistical analysis and prediction model. 
All values are presented as median±SEM (25th,75th percentiles) except where noted. Group 1 
(retrospective cohort) was used to develop an algorithm to predict the primary outcome. Each of 
the clinical, spectral and time-domain VF variables underwent univariate analysis to evaluate its 
association with in-hospital FNP.  Normal distribution of variables was assessed with  the 
Shapiro-Wilk test. Statistical significance was assessed by the parametric T-test or the non-
parametric Mann-Whitney-Wilcoxon test, as appropriate. If necessary, we used Bonferroni 
correction for multiple comparisons. Categorical variables and percentile comparisons were 
performed using a Chi-squared test or the Fisher Exact test, as appropriate. P<0.05 was 
considered statistically significant. Non-correlated variables, among statistically significant ones, 
and clinically-relevant variables were regressed out against the primary outcome by using a 
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stepwise backward multivariate logistic regression approach.[14, 15] All variables were 
standardized before entering into the multivariate analysis. We considered clinically-relevant 
variables to avoid bias, even though some were non-significant or not associated to the primary 
outcome. Interestingly, the multivariate analysis resulted in the same prediction model either 
including all relevant clinical variables or not. Based on the prior correlation results and clinical 
relevance, all variables considered in the multivariate analyses were the following: 
• Clinical variables: Atrial fibrillation, heart failure, number of shocks delivered before 
return of spontaneous circulation (ROSC), time to advance life support (ALS), time 
performing ALS, age, previous myocardial infarction (MI), previous stroke, chronic renal 
failure.  
• Fundamental and derived VF variables with the highest univariate prediction accuracy 
among highly correlated variables: DF, HL-pKR, HL-PSDR, NSC, PSD80%. 
The multivariate logistic regression was performed using a backward iterative approach to 
eliminate variables and search for the best performance model, which was determined by the 
ROC curves obtained for each classification (maximum squared root product of sensitivity and 
specificity and maximum C-stat). We aimed at predicting the primary outcome with the highest 
sensitivity and specificity achievable using the minimum number of variables that guarantied the 
best performance and predictive accuracy (ACC, percentage of correctly classified observations). 
Such a predictive model was validated on the prospective cohort. The model was also tested on 
both cohorts to predict outcomes at follow-up.  
To correct for bias, confidence intervals (95%) were found using bias corrected and accelerated 
bootstrap.[16] Robustness of the correlation between the outcome and expected outcome was 
challenged using the Jackknife approach to ensure stability beyond individual observations 
showing that the classification was significantly different from a random classification (p<0.001).  
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Finally, patients from both groups were categorized according to their risk scores obtained in the 
multivariate analysis. Using the best probability threshold obtained by the prediction model on 
the retrospective cohort we defined four risk subsets of the population for non-FNP as follows: 
very low and low risk of non-FNP (expected FNP), high and very high risk of non-FNP (expected 
non-FNP).  
In order to assess the relative contribution of the spectral parameters within the best prediction 
model (Model I) we evaluated a model built from the spectral predictors alone (Model II) and 
compared its performance and overall accuracy with: a) a model built using the only clinical 
variable in our prediction model (Model III), b) a model built from the most associated clinical 
variables to the primary outcome (FNP) in the retrospective cohort (Model IV), c) a model 
including both associated clinical variables and the most relevant clinical variables (Model V) 
(Supplemental Table 6). Variables included after backward elimination in Model V are described 
below. 
• Model I (Best performance model, 4 variables): DF, HL-PSDR, HL-pKR and number of 
shocks delivered before ROSC. 
• Model II (3 spectral variables): DF, HL-PSDR and HL-pKR. 
• Model III (1 clinical variable): number of shocks delivered before ROSC. 
• Model IV (Best clinical model, 5 variables): number of shocks delivered before ROSC, time 
to ALS, time performing ALS, heart failure (HF), history of atrial fibrillation (AF). 
• Model V (Associated and clinical relevant variables, 8 variables): age, number of shocks 
delivered before ROSC, time performing ALS, HF, history of previous MI, history of AF, 
history of previous stroke and chronic renal failure. Time to ALS and LVEF after hypothermia 
were excluded automatically by the backward elimination approach. 
All analyses were done using SSPS v21 and custom Matlab scripts for mathematical assistance.  
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Supplemental Figure legends. 
Supplemental Figure 1. Correlation analysis of spectral variables. Both linear (R Pearson) and 
monotonic (Rho Spearman) correlation coefficients were calculated among spectral and temporal 
ventricular fibrillation variables significantly associated to favorable neurological performance. 
Arrows highlight strong linear and monotonic correlation between DF and MF, AMSA and 
AppEnt in the retrospective cohort. AMSA= amplitude spectrum area. AppEnt= Approximate 
Entropy Regularity Index. DF= dominant frequency. HLpKR= High-to-Low peak ratio. 
HLPSDR= High-to-Low PSD ratio. MF= median frequency. NSC= normalized spectral 
concentration. PSD= power spectral density. RI= Spectral regularity index. 
 
Supplemental Figure 2. Causes of ventricular fibrillation across population (N=61). 
 
Supplemental Figure 3. Individual outcomes and follow-up. A. Quadrant-based representation 
of outcomes and follow-up of each individual patient. Patients are sorted in each quadrant 
whether they belong to the retrospective (top, R) or prospective (bottom, P) cohorts. Follow-up 
(F) of patients who survived to hospital discharge (H) is shown on the right for each group. 
Transitions during follow-up are indicated with a dashed line. Each color represents one patient. 
Markers represent each quadrant condition (circles; FNP+S, downward triangle; FNP+Non-S, 
upward triangle; Non-FNP+S and squares; Non-FNP+Non-S). B. Pie charts showing deaths at 
follow-up and deaths despite FNP. FNP= Favorable neurological performance. S= Survival. 
 
Supplemental Figure 4. ROC curves for the best performance prediction model. A. ROC curve 
for in-hospital favorable neurological performance in the retrospective cohort (C-stat= 0.98). B. 
ROC curve for the secondary end-point (survival) in the retrospective cohort (C-stat= 0.95). C. 
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ROC curve for the primary outcome in the prospective cohort. (C-stat= 0.89). D. ROC curved for 
survival to hospital discharge in the prospective cohort (C-stat= 0.92).  
 
Supplemental Figure 5. Individual variability of spectral predictors and risk score. A. VF 
tracing with superimposed 3-s sliding windows that were used to obtain spectral components 
from the DC shock up to the available signal length (maximum available=12 s). VF spectrum was 
obtained for each segment and the spectral components were estimated. B. Sequential spectral 
components along 3-s segments (‘t’ seconds prior to the DC shock) in a patient with FNP (B1) 
and a patient with non-FNP (B2). Both patients showed consistent spectral components in time. 
C. Degree of variability on spectral components assessed by the standard deviation (SD) of the 
difference on each measure for all segments, over absolute mean of the individual risk score for 
each patient. Despite the individual variability, all patients were classified within their stratified 
risk score group. D. Superimposed risk score classification for neurological performance based 
on the probability assigned by the multivariate model using both the averaged estimation for each 
predictor and the single up-to-5s segment estimation. Risk score reproducibility was confirmed 
by comparison of the outcome results between both estimations. Both approaches showed the 
same derived statistics (sensitivity, specificity, C-stat) and best performance threshold for 
classification. Confidence interval (IC95) is shown in shaded blue for the averaged risk score 
fitting. VF= ventricular fibrillation. FNP as in Supplemental Figure 3. 
 
Supplemental Figure 6. DF and risk score of the study population compared with a control 
population of VF patients without comatose status after DC shock. A. Boxplot quantification of 
DF in patients with DF≥Th (n=39), DF<Th (n=22) and Controls (n=11) (Threshold=3.9 Hz). 
Individual observations (patients) are shown in blue circles spread over the boxplots. Significant 
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differences were found between Controls and patients with DF<Th (p<0.001). B. Risk score 
classification for all patients from each group. All Controls were properly classified within 
favorable neurological performance, as expected. Red dots are outliers at least twice the 
interquartile range (25-75%) from the median. Th=Threshold. VF= ventricular fibrillation. 
 
Supplemental Figure 7. Comparison of the number of shocks delivered during resuscitation 
between groups with high and low DF. A. A significantly higher number of shocks delivered 
before ROSC was present in patients with DF values<Threshold (Th) (3.9 Hz). Individual 
observations (patients) are shown in blue circles spread over the boxplots. Red dots are outliers at 
least twice the interquartile range (25-75%) from the median. B. No significant differences 
between groups were found in the number of shocks delivered before conversion to non-VF 
rhythms. DF and VF as in Supplemental Figures 1 and 5, respectively.    
 
Supplemental Figure 8: Representative VF recordings with a DF peak close to the cut-off value 
(3.9 Hz). Upper panel, digitized trace before the first DC shock. Lower panel, representative 
spectra of the VF signal. Blue color filing shows low spectral bands (1.5 to 3.9 Hz) and red filling 
shows high spectral bands. Despite a DF peak at 3.97 Hz, both HL-PSDR (2.12) and HL-pKR (3) 
aided in correctly classifying such a case within low risk of non-favorable neurological 
performance: Risk score Log (odds); Log (-1.79). DF and VF as in Supplemental Figures 1 and 5, 
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